Treatment Strategies for Filamentous Fungi Keratitis.
Cornea
Filamentous fungi
Fusarium keratitis
Infection
Keratomycosis
Natamycin
Journal
Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864
Informations de publication
Date de publication:
03 Jul 2024
03 Jul 2024
Historique:
received:
21
05
2024
accepted:
13
06
2024
medline:
3
7
2024
pubmed:
3
7
2024
entrez:
3
7
2024
Statut:
aheadofprint
Résumé
This research aims to describe clinical findings, epidemiology and treatment outcomes in patients with filamentous fungi keratitis of a tertiary centre in Germany over a 7-year period and to compare the efficacy of different antifungal treatments and the effect of additive topical steroids. This retrospective study included 25 eyes of 23 patients from October 2013 to December 2020 with cultural isolates of filamentous fungi and corresponding keratitis. Best-corrected visual acuity (BCVA), clinical signs, symptoms, risk factors and outcome were extracted from medical records. Improvement of BVCA was noted in 68% of eyes. Mean BCVA of the study population increased from 0.75 logMAR [median 0.40, standard deviation (SD) 0.82, range 0-2.3] to 0.48 logMAR (median 0.10, SD 0.88, range - 0.1 to 3). The most commonly used antifungal topical treatment was a combination of natamycin 5% and voriconazole 2% (44% of eyes), followed by voriconazole 2% in 36% of cases. An antiinflammatory topical steroid was applied in 52%. In 16% of the eyes, penetrating keratoplasty (pKP) was performed. Diagnosis of filamentous fungi keratitis is often difficult or delayed. Outcomes can be poor even with intensive treatment because of high resistance to common antifungals. Access to natamycin 5% seems to lead to favourable outcomes in filamentous fungi keratitis.
Identifiants
pubmed: 38958844
doi: 10.1007/s12325-024-02929-3
pii: 10.1007/s12325-024-02929-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Nielsen SE, Nielsen E, Julian HO, et al. Incidence and clinical characteristics of fungal keratitis in a Danish population from 2000 to 2013. Acta Ophthalmol. 2015;93(1):54–8.
doi: 10.1111/aos.12440
pubmed: 24836583
Brown L, Leck AK, Gichangi M, Burton MJ, Denning DW. The global incidence and diagnosis of fungal keratitis. Lancet Infect Dis. 2021;21(3):e49–57.
doi: 10.1016/S1473-3099(20)30448-5
pubmed: 33645500
Walther G, Stasch S, Kaerger K, et al. Fusarium keratitis in Germany. J Clin Microbiol. 2017;55(10):2983–95.
doi: 10.1128/JCM.00649-17
pubmed: 28747368
pmcid: 5625384
Roth M, Daas L, Renner-Wilde A, et al. The German keratomycosis registry: initial results of a multicenter survey. Ophthalmologe. 2019;116(10):957–66.
doi: 10.1007/s00347-019-0871-9
pubmed: 30810837
Cheikhrouhou F, Makni F, Neji S, et al. Epidemiological profile of fungal keratitis in Sfax (Tunisia). J Mycol Med. 2014;24(4):308–12.
doi: 10.1016/j.mycmed.2014.06.047
pubmed: 25442924
Hoffman JJ, Burton MJ, Leck A. Mycotic keratitis-a global threat from the filamentous fungi. J Fungi (Basel), 2021;7(4):273.
Bullock JD, Warwar RE, Elder BL, Khamis HJ. Microbiological investigations of ReNu plastic bottles and the 2004 to 2006 ReNu with MoistureLoc-related worldwide fusarium keratitis event. Eye Contact Lens. 2016;42(3):147–52.
doi: 10.1097/ICL.0000000000000175
pubmed: 26332133
Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613.
doi: 10.1128/CMR.00113-16
pubmed: 28356323
pmcid: 5475221
Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19(3):210–20.
doi: 10.1111/1469-0691.12126
pubmed: 23398543
Behrens-Baumann W. [Keratomycosis: diagnosis and therapy]. Ophthalmologe. 2009;106(5):471–80; quiz 481.
Thomas PA, Leck AK, Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br J Ophthalmol. 2005;89(12):1554–8.
doi: 10.1136/bjo.2005.076315
pubmed: 16299128
pmcid: 1772991
Winiarczyk M, Borkowska A, Mackiewicz J. Fusarium keratitis as a growing problem—case report and literature review. Ann Agric Environ Med. 2021;28(3):409–13.
doi: 10.26444/aaem/128682
pubmed: 34558262
Zhivov A, Stachs O, Stave J, Guthoff RF. In vivo three-dimensional confocal laser scanning microscopy of corneal surface and epithelium. Br J Ophthalmol. 2009;93(5):667–72.
doi: 10.1136/bjo.2008.137430
pubmed: 18650213
Hau SC, Dart JK, Vesaluoma M, et al. Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy. Br J Ophthalmol. 2010;94(8):982–7.
doi: 10.1136/bjo.2009.175083
pubmed: 20538659
Manikandan P, Abdel-Hadi A, Randhir Babu Singh Y, et al. Fungal keratitis: epidemiology, rapid detection, and antifungal susceptibilities of fusarium and aspergillus isolates from corneal scrapings. Biomed Res Int. 2019;2019:6395840.
doi: 10.1155/2019/6395840
pubmed: 30800674
pmcid: 6360544
Szaliński M, Zgryźniak A, Rubisz I, Gajdzis M, Kaczmarek R, Przeździecka-Dołyk J. Fusarium keratitis-review of current treatment possibilities. J Clin Med. 2021;10(23):5468.
Sharma S, Das S, Virdi A, et al. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial. Br J Ophthalmol. 2015;99(9):1190–5.
doi: 10.1136/bjophthalmol-2014-306485
pubmed: 25740805
Khurana A, Kumar A, Chauhan L. Clinical profile and treatment outcomes of Fusarium keratitis. Indian J Ophthalmol. 2022;70(3):852–9.
doi: 10.4103/ijo.IJO_999_21
pubmed: 35225530
pmcid: 9114586
Brown L, Kamwiziku G, Oladele RO, et al. The case for fungal keratitis to be accepted as a neglected tropical disease. J Fungi (Basel). 2022;8(10):1047.
Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol. 2003;51(4):315–21.
pubmed: 14750619
Lin Y, Zhang J, Han X, Hu J. A retrospective study of the spectrum of fungal keratitis in southeastern China. Ann Palliat Med. 2021;10(9):9480–7.
doi: 10.21037/apm-21-1949
pubmed: 34628873
Kovalchuk B, Khoramnia R, Tóth M, Horner S, Auffarth GU, Augustin VA. Fusarium keratitis-an upcoming threat in Germany? Ophthalmologie. 2022;119(10):1022–34.
doi: 10.1007/s00347-022-01646-y
pubmed: 35925324
Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am J Ophthalmol. 2007;143(6):940–4.
doi: 10.1016/j.ajo.2007.02.030
pubmed: 17408586
pmcid: 1973090
Roth M, Steindor F, Kurzai O, Behrens-Baumann W, Mackenzie CR, Geerling, G. Mykotische Keratitis: Klinische Zeichen, Diagnose, Therapie. Augenheilkunde Up2date. 2020;10:8–16.
Hoffman JJ, Yadav R, Sanyam SD, et al. Topical chlorhexidine 0.2% versus topical natamycin 5% for the treatment of fungal keratitis in Nepal: a randomized controlled noninferiority trial. Ophthalmology. 2022;129(5):530–541.
Prajna NV, Krishnan T, Mascarenhas J, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131(4):422–9.
doi: 10.1001/jamaophthalmol.2013.1497
pubmed: 23710492
pmcid: 3769211
Ansari Z, Miller D, Galor A. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep. 2013;7(3):209–18.
doi: 10.1007/s12281-013-0150-1
pubmed: 24040467
pmcid: 3768010
Ong HS, Fung SSM, Macleod D, Dart JKG, Tuft SJ, Burton MJ. Altered patterns of fungal keratitis at a london ophthalmic referral hospital: an eight-year retrospective observational study. Am J Ophthalmol. 2016;168:227–36.
doi: 10.1016/j.ajo.2016.05.021
pubmed: 27287820
pmcid: 4977014
Labbé A, Khammari C, Dupas B, et al. Contribution of in vivo confocal microscopy to the diagnosis and management of infectious keratitis. Ocul Surf. 2009;7(1):41–52.
doi: 10.1016/S1542-0124(12)70291-4
pubmed: 19214351
Sengupta S, Rajan S, Reddy PR, et al. Comparative study on the incidence and outcomes of pigmented versus non pigmented keratomycosis. Indian J Ophthalmol. 2011;59(4):291–6.
doi: 10.4103/0301-4738.81997
pubmed: 21666314
pmcid: 3129754
Behrens-Baumann W, Finis D, MacKenzie C, Roth M, Geerling G. Keratomycosis—therapy standards and new developments. Klin Monbl Augenheilkd. 2015;232(6):754–64.
pubmed: 26084964
Prajna NV, Krishnan T, Rajaraman R, et al. Effect of oral voriconazole on fungal keratitis in the mycotic ulcer treatment trial II (MUTT II): a randomized clinical trial. JAMA Ophthalmol. 2016;134(12):1365–72.
doi: 10.1001/jamaophthalmol.2016.4096
pubmed: 27787540
pmcid: 6044431
Prajna NV, Krishnan T, Rajaraman R, et al. Adjunctive oral voriconazole treatment of fusarium keratitis: a secondary analysis from the mycotic ulcer treatment trial II. JAMA Ophthalmol. 2017;135(6):520–5.
doi: 10.1001/jamaophthalmol.2017.0616
pubmed: 28426856
pmcid: 5847083
Behrens-Baumann W. Adjunctive corticosteroids for antimicrobial treatment. Ophthalmologe. 2016;113(11):964–5.
doi: 10.1007/s00347-016-0352-3
pubmed: 27550222
Schmack I, Müller M, Kohnen T. Microbial keratitis—part 2: specific aspects of mycotic and acanthamoeba keratitis. Klin Monbl Augenheilkd. 2018;235(4):511–30.
pubmed: 29490392
Sharma N, Sahay P, Maharana PK, et al. Management algorithm for fungal keratitis: the TST (topical, systemic, and targeted therapy) protocol. Cornea. 2019;38(2):141–5.
doi: 10.1097/ICO.0000000000001781
pubmed: 30334872
Prajna NV, Krishnan T, Mascarenhas J, et al. Predictors of outcome in fungal keratitis. Eye (Lond). 2012;26(9):1226–31.
doi: 10.1038/eye.2012.99
pubmed: 22744392
Maier P, Böhringer D, Reinhard T. Clear graft survival and immune reactions following emergency keratoplasty. Graefes Arch Clin Exp Ophthalmol. 2007;245(3):351–9.
doi: 10.1007/s00417-006-0410-7
pubmed: 17024439
Iselin KC, Baenninger PB, Schmittinger-Zirm A, Thiel MA, Kaufmann C. Fungal keratitis: a six-year review at a tertiary referral centre. Klin Monbl Augenheilkd. 2017;234(4):419–25.
doi: 10.1055/s-0042-123233
pubmed: 28376553
Kim JS, Kim JC, Hahn TW, Park WC. Amniotic membrane transplantation in infectious corneal ulcer. Cornea. 2001;20(7):720–6.
doi: 10.1097/00003226-200110000-00010
pubmed: 11588424
Ma DH, Wang SF, Su WY, Tsai RJ. Amniotic membrane graft for the management of scleral melting and corneal perforation in recalcitrant infectious scleral and corneoscleral ulcers. Cornea. 2002;21(3):275–83.
doi: 10.1097/00003226-200204000-00008
pubmed: 11917176
Lin HC, Chu PH, Kuo YH, Shen SC. Clinical experience in managing Fusarium solani keratitis. Int J Clin Pract. 2005;59(5):549–54.
doi: 10.1111/j.1368-5031.2005.00399.x
pubmed: 15857351
Watson SL, Cabrera-Aguas M, Keay L, Khoo P, McCall D, Lahra MM. The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney. Australia Mycoses. 2020;63(1):43–51.
doi: 10.1111/myc.13009
pubmed: 31556179